XML 57 R51.htm IDEA: XBRL DOCUMENT v3.22.2.2
Financial Assets and Liabilities - Summary of Valuation Processes of Contingent Consideration at Fair Value (Details) - USD ($)
$ in Thousands
Sep. 30, 2022
Jun. 30, 2022
Disclosure Of Financial Instruments [Abstract]    
Fair value of cash or stock payable, dependent on achievement of future late-stage clinical or regulatory targets $ 17,650 $ 17,827
Fair value of royalty payments from commercialization of the intellectual property acquired 3,851 5,457
Contingent Consideration $ 21,501 $ 23,284